Dr. Osama Khaled Ali Kaddourah, MD

Dr. Kaddourah practices at University of Maryland Upper Chesapeake Medical Center Bel Air in Bel Air, Maryland, part of University of Maryland Medical System.

Dr. Kaddourah's NPI, 1619358181, was assigned on June 10, 2015. Dr. Kaddourah holds Maryland license D0092318.

Dr. Kaddourah's primary practice is University of Maryland Upper Chesapeake Medical Center Bel Air, at 500 Upper Chesapeake Drive, Bel Air, MD 21014 in Harford County. The practice phone is (443) 643-3303.

Dr. Kaddourah's primary practice is University of Maryland Upper Chesapeake Medical Center Bel Air in Bel Air, Maryland, part of University of Maryland Medical System. Dr. Kaddourah is also affiliated with University of Maryland Medical Center. The medical group on file is University of Maryland Medical Center Gastroenterology and Hepatology. Dmand AI also links Dr. Kaddourah to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaddourah practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kaddourah's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Kaddourah's licenses on file in 2 states: Maryland and Missouri.

CMS data shows 1,387 Medicare services from Dr. Kaddourah across 17 procedure codes in 2024, for 811 Medicare patients. Medicare paid $128,441 for them.

CMS counts 811 Medicare patients who saw Dr. Kaddourah in 2024. The largest group is 65 to 74, with 402 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaddourah's median patient age at 66, with 48% women.

In 2024, Dr. Kaddourah wrote 1,125 Medicare Part D claims for 373 patients. 83% of them were for generic drugs. CMS names the drug for 918 of them, across 17 drugs with 11 or more claims each, at $49,783 in total drug cost. In 2023, CMS named 1,145 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Kaddourah for performance year 2024, reported as part of a group. Dr. Kaddourah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 90 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Kaddourah, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Kaddourah, published from 2018 to 2020. 2018 was the busiest year, with 2. Dr. Kaddourah's most frequent co-authors are Mouhanna Khaled Mahmoud Abu Ghanimeh, MD, Laith Mansour Numan, MD and Sakher M. Albadarin, MD.

CMS Open Payments shows 11 general payments to Dr. Kaddourah from 5 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 94% of the total. Gilead Sciences, Inc. paid the most, $234.